Tanya Pharma Private Limited
About Tanya Pharma Private Limited
Data last updated:
Tanya Pharma Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Silverline Holdings Pvt Ltd. It operates in the real estate financing segment of the financial services sector. It was incorporated on 20 May 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PTC059153.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandeep Handa and Harsh Kumar Gupta.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 404 Nirmal Tower 26 Barakhamba Road, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.88 Lakh, a decline of 89% compared to the previous year. For the same year it recorded a net profit of ₹11.17 Lakh (net margin 228.9%) and EBITDA of ₹4.55 Lakh (EBITDA margin 93.2%). Revenue has grown at a compounded annual rate (CAGR) of 66% over three years and 49% over five years.
As per MCA filings, the company has satisfied charges of ₹55 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Tanya Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address404 Nirmal Tower 26 Barakhamba Road, New Delhi, Delhi, India – 110001
- IndustryFinancial Services, Real Estate Financing
To see the full contact details of Tanya Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tanya Pharma is real estate activities. In detail, this covers real estate activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| L | Real estate activities | 68 | Real estate activities |
To see the full business activity and turnover split of Tanya Pharma Private Limited, buy the company report.
Financials of Tanya Pharma Private Limited
FY 2025 filings availableTanya Pharma Private Limited reported revenue of ₹4.88 Lakh (down 89% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 89% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 49%. EBITDA fell 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 93.2% | ||||
| Net Profit Margin | 228.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tanya Pharma Private Limited, buy the company report.
Board of directors of Tanya Pharma Private Limited
Tanya Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Handa Also directs: Blue Stone Estate Pvt. Ltd., Indique Estates Private Limited, Goldshine Apartment Private Limited and 5 more | Director | 03 Aug 2007 | 19 Years 2 Months | Current |
| Harsh Kumar Gupta Also directs: Arsa Trading and Finance Pvt. Ltd., Everlike Properties Private Limited, Aman Developers Private Limited and 5 more | Director | 15 Feb 2019 | 7 Years 8 Months | Current |
Auditor
Tanya Pharma Private Limited is audited by K P M R & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K P M R & ASSOCIATES | FY 2020 | 002504N |
Shareholding
The shareholding of Tanya Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Tanya Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Mar 2009 | 10150643 | Il&Fs Financial Services Limited | ₹55 Cr | Satisfied |
To see the full charge records of Tanya Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Tanya Pharma Private Limited has 2 court cases on record: 2 filed by Tanya Pharma. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
| High courts | 1 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, HARYANA | Appeal | Filed by the company against an individual | Pending |
| District court, Nuh, Haryana | Appeal | Filed by the company against an individual | Disposed |
To see the full case history of Tanya Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tanya Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Tanya Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Tanya Pharma Private Limited has 6 board changes on record since 2007: 2 appointments and 4 cessations. The latest: Harsh Kumar Gupta ceased to be Additional Director on 26 Sep 2019.
Frequently asked questions
Tanya Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in real estate financing, within the financial services industry. It was incorporated on 20 May 1994 (32+ years old) and is registered under CIN U74899DL1994PTC059153.
Tanya Pharma has 2 current directors:
- Sandeep Handa - Director
- Harsh Kumar Gupta - Director
The latest financial statements of Tanya Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Tanya Pharma is U74899DL1994PTC059153. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tanya Pharma has 2 court cases on record: 2 filed by the company. 1 is pending. Most are in the district courts.
Tanya Pharma was incorporated on 20 May 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.
Harsh Kumar Gupta ceased to be Additional Director on 26 Sep 2019. Shiv Kishan Hazari ceased to be Director on 27 Feb 2019. Harsh Kumar Gupta was appointed as Director on 15 Feb 2019. Tanya Pharma has 6 board changes on record in total.
The registered office of Tanya Pharma is at 404 Nirmal Tower 26 Barakhamba Road, New Delhi, Delhi, India – 110001.
Tanya Pharma operates in the financial services industry, in the real estate financing segment.
Tanya Pharma has no open charges and satisfied charges of ₹55 Cr as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
